Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 3, 2024 | Obsidian Therapeutics | $160.5M Series C | Irina Margine, Ph.D. | Atlas Venture, Bristol Myers Squibb, Deep Track Capital, Foresite Capital, Janus Henderson Investors, Logos Capital, Ray Camahort, RA Capital Management, RTW Investments, Samsara BioCapital, Surveyor Capital, TCGX, T. Rowe Price Associates, Woodline Partners |
| Aug 17, 2023 | COMPASS Pathways | $285.1M Other Equity | Aisling Capital, TCGX | Armistice Capital, Laurion Capital Management, Logos Capital, PFM Health Sciences, RA Capital Management, Soleus Capital, Surveyor Capital, Vivo Capital |